← SynDRA
angiogenesis-inhibitor
SynDRA canonical compound SYN0086871 — structure-anchored drug synonym record
| Primary target(s) | EGFR |
|---|
| Mechanism of action | Angiogenesis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADGRF1
- NEIL1
- HDAC6
- HSD17B10
- KDM4E
- MBD4
- MPG
- MUTYH
- NEIL2
- GPR119
- NTHL1
- OGG1
- S1PR1
- SMUG1
- TDG
- TDP1
- GPR35
- GLP1R
- ADRA2A
- CX3CR1
- ADRB2
- AGTR1
- ALDH1A1
- ALOX15
- APLNR
- C5AR1
- CYP1A2
- FPR2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- FFAR4
- FPR1
- UNG
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- (Z,E)-3-(Imidazol-4-ylmethylene)indolin-2-one
- AngiogenesisInhibitor
- (3E)-3-(1H-imidazol-5-ylmethylidene)-1H-indol-2-one
- 6HR3NM6GJV
- K00007
- SCHEMBL2998488
- CHEBI:92147
- HSCI1_000093
- BRD-K08502430-001-01-0
Look up angiogenesis-inhibitor in the interactive SynDRA portal →